Free product worth Rs 499 on all myUpchar products
Mego Plus is an allopathic medicine The correct dosage of Mego Plus depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Mego Plus is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Mego Plus safe for pregnant women?
Mego Plus is safe for pregnant women.
Is the use of Mego Plus safe during breastfeeding?
Mego Plus does not show any harmful effects in lactating women.
What is the effect of Mego Plus on the Kidneys?
Mego Plus rarely harms the kidneys.
What is the effect of Mego Plus on the Liver?
The liver can be affected by Mego Plus. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Mego Plus only after medical advice.
What is the effect of Mego Plus on the Heart?
No research work has been carried out till date on effects of Mego Plus on heart. So it is not known whether taking Mego Plus will cause side effects on heart or not.
Mego Plus should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Mego Plus unless your doctor advises you to do so -
Is this Mego Plus habit forming or addictive?
Mego Plus does not cause addiction.
Interaction between Food and Mego Plus
When consumed with certain foods, Mego Plus may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Mego Plus
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Mego Plus.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alpha Lipoic Acid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 609-611
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
